自拍无码精品一区二区|亚洲А∨天堂久久精品|国产日韩欧美一区二区视|亚洲av高清dvd丝袜|中文一级无码黄片精品视频|亚洲无码网站在线免费观看|免费无码又爽又刺激又污又黄|成人免费无码婬片在线观看免费

  • <tfoot id="icskm"></tfoot>
  • <code id="icskm"><xmp id="icskm"></xmp></code>
  • <li id="icskm"><input id="icskm"></input></li>
    <code id="icskm"></code>
  • <cite id="icskm"><center id="icskm"></center></cite><button id="icskm"><bdo id="icskm"></bdo></button><code id="icskm"></code>
  • <cite id="icskm"><pre id="icskm"></pre></cite>
    <button id="icskm"></button>
  • <rt id="icskm"><pre id="icskm"></pre></rt>
    <cite id="icskm"></cite>
    <li id="icskm"></li>
    <button id="icskm"><input id="icskm"></input></button>
  • 159-2642-3062 027-65317797
    服務熱線(工作日:9:00-17:30)

    瀏覽量: 226

    • 產(chǎn)品名稱: Research Grade Idarucizumab ( 艾達賽珠單抗 )
    • 產(chǎn)品貨號: CSD00317
    • 貨期: 現(xiàn)貨
    • 價格與訂購: 2480
    • 數(shù)量:
      庫存: 100
    • 規(guī)格: 100μg
    • 產(chǎn)品信息
    • 如何訂購
      貨號(Catalog No.)
      CSD00317
      通用名INN
      Idarucizumab
      純度(Purity)
      >95%
      濃度( Concentration)
      1mg/ml
      Formulation
      PBS buffer PH7.5
      Source
      CHO cells
      內毒素(Endotoxin level)
      Please contact with the lab for this information.
      產(chǎn)品描述(Description)
      Idarucizumab is a humanized monoclonal antibody fragment (Fab) derived from an immunoglobulin G1 isotype molecule that binds to and inactivates the oral anticoagulant dabigatran, thereby reversing its anticoagulant effect. As a direct acting oral anticoagulant (DOAC), one of the risks associated with the use of dabigatran includes bleeding, espeically when given to patients at increased risk (elderly, chronic kidney disease, concomitant NSAID or warfarin use, etc).Approved under the tradename Praxbind (FDA), idarucizumab is indicated for the emergency treatment of dabigatran-associated bleeding in life-threatening or surgically induced situations. Its use is associated with immediate, complete and sustained reversal of the anticoagulant effects of dabigatran.Idarucizumab protein structure can be viewed below, with disulfide bridges at the following points: H22-H95, H149-H205, H225-L-219, L23-L93, L139-L199.
      別名(Alternative names)
      aDabi-Fab,anti-dabigatran,antidote for dabigatran
      靶點;物種(Specificity target name;species)
      MS4A1[Homo sapiens]
      活性研究(體外/體內研究)(Activity in vitro)
      Dabigatran selectively and reversibly inhibited human thrombin(Ki: 4.5 nM) as well as thrombin-induced platelet aggregation (IC50: 10 nM), while showing no inhibitory effect on other platelet-stimulating agents. Thrombin generation in platelet-poor plasma (PPP), measured as the endogenous thrombin potential (ETP) was inhibited concentration-dependently (IC50: 0.56 μM). Dabigatran demonstrated concentration-dependent anticoagulant effects in various species in vitro, doubling the activated partial thromboplastin time (aPTT), prothrombin time (PT) and ecarin clotting time (ECT) in human PPP at concentrations of 0.23, 0.83 and 0.18 μM, respectively.
      種類(Species)
      Humanized
      受體鑒定(Receptor identification)
      Fab
      CAS
      1362509-93-0
      存儲條件(Storage)
      Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
      Store at +4°C short term (1-2 weeks).
      Store at -20 °C 12 months.
      Store at -80°C long term.
      Note
      For research use only .
    南涧| 石首市| 贵南县| 稷山县| 岳普湖县| 阿克| 绵竹市| 龙井市| 伊宁县| 措勤县| 阳原县| 金昌市| 海盐县| 闻喜县| 翁源县| 四川省| 桂东县| 称多县| 静安区| 大安市| 阿尔山市| 安福县| 辽阳县| 丽水市| 兴仁县| 滦南县| 凌海市| 彰武县| 横山县| 云和县| 石楼县| 广河县| 岗巴县| 九江县| 普洱| 文化| 普格县| 邻水| 苏尼特右旗| 神池县| 新乡县|